Juno Therapeutics plummets 30% in pre-market trade
Post# of 72447

http://www.marketwatch.com/story/juno-therape...2016-11-23
Those who tried to downplay the success of Kevetrin Phase 1 should be ashamed.


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
